Results 181 to 190 of about 64,206 (250)

IL-1 Blockade to Resolve Persistent Inflammation After STEMI. [PDF]

JACC Basic Transl Sci
Del Buono MG, Golino M, Abbate A.
europepmc   +1 more source

Racial and Ethnic Disparities in Acute Myocarditis Outcomes in the United States

Clinical Cardiology, Volume 49, Issue 9, September 2026.
In a nationally representative analysis of 105 235 U.S. hospitalizations for acute myocarditis, racial and ethnic minority groups had higher adjusted in‐hospital mortality than White patients. Asian/Pacific Islander patients had the greatest mortality and hemodynamic risk, while Black and Hispanic patients showed distinct complication patterns ...
Maria F. Osorio, Paola Lecompte‐Osorio, Sebastian Vasquez‐Ariza, Michael Dangl, Louis Vincent, Johanna Contreras, Rosario Colombo   +6 more
wiley   +1 more source

Sex-based differences in developing heart failure after ST-segment elevation myocardial infarction. [PDF]

Front Cardiovasc Med
Xie Y, Wang W, Song X, Gao M, Zhang F, Li Y, Wang J, Dang Y, Qi X.   +8 more
europepmc   +1 more source

Association of a Low Eosinophil-to-Monocyte Ratio With One-Month All-Cause Mortality in Patients With ST-Segment Elevation Myocardial Infarction: A Cohort Study. [PDF]

Cureus
Pervaiz S, Javed Z, Asghar A, Khaqan A, Jilani SMA, Hameed A, Changazi SH.   +6 more
europepmc   +1 more source

Lower Admission CALLY Index Is Associated with Contrast-Associated Acute Kidney Injury in Patients with STEMI Undergoing Primary PCI. [PDF]

Medicina (Kaunas)
Eynel E, Yılmaz D, Nyyazov A, Eynel E, Kocayiğit I, Aksoy MNM.   +5 more
europepmc   +1 more source

Antithrombotic Therapy in Coronary Artery Aneurysm, Ectasia, and Slow Flow: A Systematic Review

Clinical Cardiology, Volume 49, Issue 9, September 2026.
Antithrombotic therapy for coronary artery aneurysm, coronary artery ectasia, and coronary slow‐flow phenomenon remains insufficiently defined. This review highlights limited and heterogeneous evidence, supporting individualized treatment decisions and the need for stronger comparative studies.
Nasim Kheirandish, Maliheh Kamali, Alireza Khodadadiyan, Helia Bazroodi, Mohammadhossein Imani, Sahar Ghahramani, Amirhossein Saem, Amirhossein Imani, Haniyeh Alaei, Alireza Abdi‐Ardekani, Saideh Jamshidi, Mehdi Bazrafshan, Alireza Arzhangzade, Zahra Hooshanginezhad, Hamed Bazrafshan Drissi   +14 more
wiley   +1 more source

P2Y₁₂ inhibitor pre-treatment in NSTE-ACS: translating trial evidence into UK clinical practice. [PDF]

Open Heart
Hesse K, Stephens J, Batty JA, Bayliss CD, Memon S, Loh SX, Telyuk P, Swanson N, Muir D, Jackson M, Carter J, Sutton A, Vijayan S, Williams PD, Akowuah E, Wilkinson C, Austin D.   +16 more
europepmc   +1 more source

Mechanisms and Predisposing Conditions for Statin‐Induced New‐Onset Type 2 Diabetes Mellitus: A Paradox Relative to Their Pleiotropic Metabolic Effects

Endocrinology, Diabetes &Metabolism, Volume 9, Issue 5, September 2026.
The primary function of statins is to inhibit cholesterol synthesis, which contributes to their antidiabetic effects. However, the majority of the diabetic effects of statins are due to inhibition of isoprenoid synthesis. Atorvastatin, simvastatin and rosuvastatin possess the most pronounced diabetogenic properties. In contrast, lovastatin, fluvastatin,
Ali Nosrati Andevari, Mohsen Koolivand
wiley   +1 more source

Case Report: Unmasking an anomalous coronary artery during emergency STEMI intervention: a rare diagnostic challenge with successful revascularization outcome. [PDF]

Front Cardiovasc Med
Reihan MS, Ahmed Dabash TA, Ahmed Mostafa AM, Mohammed Hammad MA, Thalib HI, Elkafory HA, Mohammed Mohyeldin MM.   +6 more
europepmc   +1 more source

A Review of the Role of Artificial Intelligence in Patients on Extracorporeal Membrane Oxygenation: A Scoping Review Study

Health Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims ECMO is used to deliver cardiopulmonary support in extreme failure where standard therapies are unfruitful. Although ECMO is associated with high costs and significant risks, advances in technology and clinical management have improved its safety and patient outcomes. AI/ML may provide decision support through data analysis
Zahra Asadi, Mahmoud Shiri Kahnouei, Fathiyeh Bahramnejad, Alun C. Jackson, Fatemeh Bahramnezhad   +4 more
wiley   +1 more source